Approval · Notice of Compliance 6004 · 2004
PUREGON (SOLUTION FOR INJECTION): Notice of Compliance 6004
Issued December 16, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6004
- Date
- December 16, 2004
- Company
- Organon Canada Inc.Kirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in dosing advice
- Therapeutic class
- Human gonadotropin
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PUREGON (SOLUTION FOR INJECTION) | Not yet assigned | — |
| PUREGON (SOLUTION FOR INJECTION IN CARTRIDGES) | Not yet assigned | — |
Medicinal ingredients
- FOLLITROPIN BETA 75 UNIT per VIAL
- FOLLITROPIN BETA 50 UNIT per VIAL
- FOLLITROPIN BETA 100 UNIT per VIAL
- FOLLITROPIN BETA 150 UNIT per VIAL
- FOLLITROPIN BETA 200 UNIT per VIAL
- FOLLITROPIN BETA 225 UNIT per VIAL
- FOLLITROPIN BETA 250 UNIT per VIAL
- FOLLITROPIN BETA 300 UNIT per CART
- FOLLITROPIN BETA 600 UNIT per CART